Dr. Marcel A. Behr
Office Phone: (514) 934 1934 x42815
Marcel Behr was the Founding Director of the McGill International TB Centre. He completed a BSc in Biochemistry at the University of Toronto, an MD at Queen’s University and residency training in Internal Medicine, Infectious Diseases and Medical Microbiology at McGill University. He also completed an MSc in Epidemiology and Biostatistics at McGill University and then did post-doctoral training in molecular epidemiology and bacterial genomics, with Peter Small, at Stanford University. He is currently a Professor of Medicine at McGill University and Associate Director of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Centre (www.idigh.ca). In addition to research activities, he attends on the Infectious Diseases consult service, he works in the TB clinic of the MUHC and he directs the mycobacteriology laboratory of the OptiLab Grappe-CUSM.
Marcel’s research employs genomic methods to study the epidemiology and pathogenesis of TB and other mycobacterial infections. His research is supported by a Foundation Grant from the CIHR and he also enjoys an active collaboration with the Structure-Based Drug Discovery Coalition (www.thesgc.org/sddc) for the development of novel anti-mycobacterial treatments. He has published more than 200 peer-reviewed publications, reviews and book chapters. In recognition of his work, he has been elected to the American Society of Clinical Investigation and is a Fellow of the Canadian Academy of Health Sciences, the Royal Society of Canada and the American Academy of Microbiology.
Tuberculosis, BCG, molecular microbiology, genomics, molecular epidemiology, non-tuberculous mycobacteria, NOD2, N-glycolyl muramyl dipeptide
Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MVS, Schlesinger LS, Divangahi M, Reed MB, Behr MA.
N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis.
J Infect Dis. 2014 Apr;209(7):1045-54.
Marcel A. Behr, W. Ray Waters.
Is tuberculosis a lymphatic disease with a pulmonary portal?
Lancet Infect Dis. 2014 Mar;14(3):250-5. doi:10.1016/S1473-3099(13)70253- 6. Epub 2013 Nov 22
Wang J, McIntosh F, Radomski N, Dewar K, Simeone R, Enninga J, Brosch R, Rocha EP, Veyrier FJ, Behr MA.
Insights on the Emergence of Mycobacterium tuberculosis from the Analysis of Mycobacterium kansasii.
Genome Biol Evol. 2015 Feb 25;7(3):856-70. doi: 10.1093/gbe/evv035
Lee RS, Radomski N, Proulx J-F, Levade I, Shapiro BJ, McIntosh F, Soualhine H, Menzies D, Behr MA.
Population genomics of Mycobacterium tuberculosis in the Inuit.
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13609-14. doi:10.1073/pnas.1507071112.
Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme C, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M.
Nature Reviews Disease Primers 2016 Oct 27;2:16076.: doi:10.1038/nrdp.2016.76